The Combination of Prognostic Nutritional Indicator and Serum Carcinoembryonic Antigen is Useful in Predicting Postoperative Recurrence in Stage II Colorectal Cancer-Reference-Cited by-同舟云学术

The Combination of Prognostic Nutritional Indicator and Serum Carcinoembryonic Antigen is Useful in Predicting Postoperative Recurrence in Stage II Colorectal Cancer

Published:2021 Issue:2 Volume:64 Page:176-183
ISSN:1346-8049
Container-title:Yonago Acta Medica
language:en
Short-container-title:Yonago Acta Med.

Author:

Uejima Chihiro¹,Saito Hiroaki²,Tada Yoichiro¹,Tanio Akimitsu¹,Murakami Yuki¹,Yamamoto Manabu¹,Matsunaga Tomoyuki¹,Fukumoto Yoji³,Tokuyasu Naruo¹,Takano Shuichi¹,Sakamoto Teruhisa¹,Honjo Soichiro¹,Fujiwara Yoshiyuki¹

Affiliation:

1. Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan

2. Department of Surgery, Japanese Red Cross Tottori Hospital, Tottori 680-8517, Japan and

3. Department of Surgery, Matsue City Hospital, Matsue 690-8509, Japan

Publisher

Tottori University Faculty of Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/yam/64/2/64_2021.05.009/_pdf

Reference21 articles.

1. 1. Marsoni S; International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. Semin Oncol. 2001;28(suppl 1):14-9. PMID:11273584, DOI:10.1016/S0093-7754(01)90246-5

2. 2. Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol. 2002;20:3999-4005. PMID:12351597, DOI:10.1200/JCO.2002.11.084

3. 3. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al.; Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350:2343-51. PMID:15175436, DOI:10.1056/NEJMoa032709

4. 4. Venook AP, Niedzwiecki D, Lopatin M, Ye X, Lee M, Friedman PN, et al. Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581. J Clin Oncol. 2013;31:1775-81. PMID:23530100, DOI:10.1200/JCO.2012.45.1096

5. 5. Inamoto S, Kawada K, Okamura R, Hida K, Sakai Y. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study. Int J Colorectal Dis. 2019;34:1303-15. PMID:31177316, DOI:10.1007/s00384-019-03316-z

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined preoperative prognostic nutritional index and D-dimer score predicts outcome in colorectal cancer;BMC Surgery;2023-02-07

2. Comparison of Proportion of Elevated Carcinoembryonic Antigen Levels in Patients With Appendiceal and Colorectal Adenocarcinoma: A Systematic Review and Meta-analysis;Anticancer Research;2022-08-23

3. Preoperative Absolute Lymphocyte Count to Carcinoembryonic Antigen Ratio Is a Superior Predictor of Survival in Stage I to III Colorectal Cancer;Clinical Medicine Insights: Oncology;2022-01